ScholarWorks@SOONCHUNHYANG UNIVERSITY: Kim, Hong Soo

Detailed Information

Kim, Hong Soo (김홍수)

College of Medicine (Department of Internal Medicine)

Research Area

Tel
E-mail
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

hepatocellular carcinoma:3||Hepatitis B virus:3||Hepatocellular carcinoma:3||Ribavirin:2||anion exchanger:2||Diagnosis:2||hepatocellular:2||Carcinoma:2||cholangiocyte:2||cholestasis:2||Hepatocyte:2||chronic hepatitis B:2||Clevudine:2||CFTR:2||Cirrhosis:1||Contrast:1||Contrast enhanced Ultrasonography (CEUS):1||Controlled attenuation parameters (CAP):1||Cyclooxygenase2:1||Drug resistance:1||Druginduced Liver Injury:1||Druginduced liver injury:1||Duodenal neoplasms:1||Endoscopic submucosal dissection:1||Entecavir:1||Etiology:1||Extrahepatic metastases:1||F18fluorodeoxyglucose positron emission tomography/computed tomography scan:1||Fanconi syndrome:1||Feeding artery:1||Fluorodeoxyglucose F18:1||Focal liver lesions (FLLs):1||Fundal varices:1||Gastric varices:1||Guidelines:1||HVPG:1||Hepatic venous pressure gradient:1||Hepatic venous pressure gradient (HVPG):1||Hepatitis B, Chronic:1||Hepatitis C virus:1||Hepatotoxicity:1||Hypertension, portal:1||Korea:1||Koreans:1||Lamivudine resistance:1||Liver Cirrhosis:1||Liver abscess:1||Liver cirrhosis:1||Liver fibrosis:1||Melena:1||Mitochondria:1||Mutation:1||Nephrotoxicity:1||Osteomalacia:1||Overlap syndrome:1||Pegylated interferon alpha2b:1||Plants, Medicinal:1||Portal vein:1||Portasystemic shunt, surgical:1||Positronemission tomography:1||Post marketing surveillance:1||Prescribed Medicines:1||Primary biliary cirrhosis:1||Prognosis:1||Proton pump inhibitors:1||Proximal tubules:1||Pyogenic:1||Radiationinduced liver disease:1||Realtime elastography:1||Renal Function:1||Restriction fragment mass polymorphism:1||Secondary prevention:1||Serum Creatinine Level:1||Sofosbuvir:1||Sorafenib:1||Spontaneous Bacterial Peritonitis:1||Stereotactic body radiation therapy:1||Stomach:1||Sustained virologic response:1||TRAIL Enhances Apoptosis of Human HepatocellularCarcinoma Cells Sensitized by Hepatitis C Virus Infection:Therapeutic Implications:1||Thrombosis:1||Tomography:1||Traditional Therapy:1||Transarterial chemoembolization:1||Transient elastography:1||Treatment outcomes:1||Tumor size:1||Ulcer:1||Variceal hemorrhage:1||Vascular endothelial growth factor:1||Viral breakthrough:1||Viral replication:1||Xray computed:1||adefovir:1||alternative treatment:1||antiviral resistance:1||antiviral therapy:1||chemoembolization:1||combination drug therapy:1||enhanced ultrasonography:1||entecavir:1||health education:1||hepatic arterial infusion chemotherapy:1||hepatic fat content:1||hepatitis B virus:1||high cost:1||hyperlipidemia:1||lamivudine:1||liver enzymes:1||liver transplantation:1||lowMELD:1||multicenter study:1||nonalcoholic fatty liver disease:1||nutrition:1||nutrition education:1||radiofrequency ablation:1||renal insufficiency:1||resistance exercise:1||sorafenib:1||stereotactic body radiotherapy:1||survival:1||survival rate:1||tenofovir:1||Acousticradiationforce impulse elastography:1||whey protein supplement:1||Adefovir:1||Afferent loop syndrome:1||Anemia:1||Autoimmune hepatitis:1||Besifovir:1||Betablocker:1||Bone mineral density:1||Bronchial fistula:1||Carcinoma, hepatocellular:1||ChildPugh score:1||Chronic hepatitis:1||Chronic hepatitis B:1||Chronic hepatitis C:1||

STATISTICS: Total View :1,199,439; Today View :98

RSS_1.0 RSS_2.0 ATOM_1.0

(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE